Fingerprint
Dive into the research topics of 'Dose modifications of ribociclib and endocrine therapy for treatment of ER+ HER2− metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dose modifications of ribociclib and endocrine therapy for treatment of ER+ HER2− metastatic breast cancer
Kristoffer B. Kristensen*, Ida Marie Nedergaard Thomsen, Tobias Berg, Annette R. Kodahl, Anders Bonde Jensen
*Corresponding author for this work
Research output: Contribution to journal › Journal article › Research › peer-review
19
Downloads
(Pure)